TickerFactsScreenerDevelopers

TScan Therapeutics, Inc. (TCRX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$26.23M2021: -$48.64M2022: -$66.64M2023: -$93.46M2024: -$134.82M2025: -$135.81M-$135.81M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$135.81M-0.7%
2024-$134.82M-44.3%
2023-$93.46M-40.3%
2022-$66.64M-37.0%
2021-$48.64M-85.4%
2020-$26.23M—